Delivery Order SPE2DR25D2003-SPE2DR26FR03Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $26,647.13. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is set for ultimate completion by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single task under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,178.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 8, 2025, with completion scheduled for December 9, 2025. This contract is unset-aside and represents a competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. The contract, valued at $10,987.57, is scheduled for completion by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger Indefinite Delivery Contract vehicle and was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,618.73 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating competitive selection. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $5,629.86 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $1,733.90. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, representing a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $3,686.07. This competitively awarded, firm fixed-price delivery order represents a continuation of the contractor's critical role in supporting federal pharmaceutical procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $27,358.58 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, executed on December 5, 2025, represents a firm fixed price delivery order with a completion date of December 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $8,001.71. This is a firm fixed price, non-competitive delivery order executed under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.78 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablets) 8mg in a quantity of 30 units. This non-competitive, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of the same day. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR03ZDelivery Order
The Defense Logistics Agency awarded a $4,885.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ondansetron ODT 8 mg tablets in a quantity of 30 units. The delivery order, issued under a non-set-aside competitive procurement, is scheduled for completion by December 17, 2025, with performance of work occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in meeting federal medical procurement requirements through its extensive portfolio of competitive contract awards with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for ondansetron, an antiemetic medication commonly used in medical settings, reflects the company's ongoing role as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 12/15/25 |